Clinical Trial Update: A Comparative Study of New Formulation and Approved Formulation for Levothyroxine in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial comparing a new formulation of levothyroxine with the approved formulation in healthy volunteers has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Individuals
• Hypothyroidism

Drugs mentioned

• Levothyroxine (levothyroxine)

Snippet

Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Conditions: Healthy | Phase 1 | Status: COMPLETED | Results posted: 2021-02-05